ARHGEF39 and nonpapillary renal cell carcinoma: Loss- and gain-of-function assays were conducted to analyze the effect of ARHGEF39 expression on the viability, migration and invasion of ccRCC cells, as well as the activation of the AKT/ERK signaling pathway.